Ella is a co-founder and general partner at Zinc VC, and co-founder of Alma Angels and NewCo UK. She previously held strategy and performance roles at IPG Mediabrands and Universal McCann.
Emilie brings life sciences and medtech investment experience from her roles at Zinc and Parkwalk Advisors. She previously worked at Oxford University Innovation and held a board position at T-Cypher Bio.
Zinc VC has led a pre-seed funding round in Native Labs to accelerate platform deployment and feature development.
"We are excited to be partnering with the Native Labs team as they build the critical infrastructure required to accelerate the development and delivery of cell therapies. Their platform is addressing one of the most challenging bottlenecks in the field, enabling more seamless, data-driven communication between developers and manufacturers. In a market that is growing rapidly, and with the potential to transform patient outcomes, Native Labs is not only solving a deeply complex technical challenge but unlocking a massive opportunity for impact across the entire cell and gene therapy ecosystem."
Fuel Ventures led the seed financing round to support market introduction.
"We are thrilled to have Fuel Ventures on board as we gear up to introduce our “employees of the future” to the commercial finance market. This investment is not just a financial boost but a strong vote of confidence in our vision and technology."
The pre-seed round was backed by investors including Zinc VC and the Google Black Founders Fund to launch the platform publicly.
"You are nine times more likely to be hired through an employee referral, however if you come from a less privileged background like me, chances are you don’t have a professional network to get referred"
